Oruka Therapeutics, Inc. (ORKA) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 | Q2'20 | Q1'20 | Q4'19 | Q3'19 |
|---|
| Total Current Assets | 395.25M | 343.86M | 355.16M | 332.01M | 352.08M | 376.87M | 412.95M | 33.82M | 36.67M | 50.54M | 54.42M | 59.67M | 64.79M | 68.73M | 49.97M | 51.94M | 11.57M | 7.38M | 8.48M | 9.9M |
| Cash & Short-Term Investments | 388.83M | 337.04M | 349.15M | 328.41M | 349.09M | 375.65M | 410.88M | 33.28M | 35.9M | 49.06M | 53.36M | 58.31M | 63.2M | 66.93M | 49.07M | 51.09M | 11.04M | 6.67M | 8.36M | 9.64M |
| Cash Only | 49.52M | 46.94M | 91.25M | 65.4M | 83.57M | 61.58M | 410.88M | 33.28M | 35.9M | 49.06M | 53.36M | 58.31M | 63.2M | 66.93M | 49.07M | 51.09M | 11.04M | 6.67M | 8.36M | 9.64M |
| Short-Term Investments | 339.31M | 290.11M | 257.9M | 263.01M | 265.52M | 314.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.42M | 6.81M | 6.01M | 3.61M | 2.99M | 1.22M | 2.07M | 537K | 767K | 1.48M | 1.06M | 1.35M | 1.6M | 1.8M | 897K | 841K | 532K | 704K | 117K | 259K |
| Total Non-Current Assets | 109.23M | 144.76M | 154.09M | 25.41M | 25.03M | 19.15M | 1.14M | 24K | 36K | 475K | 503K | 526K | 545K | 453K | 461K | 46K | 60K | 83K | 56K | 45K |
| Property, Plant & Equipment | 2M | 2.12M | 2.22M | 2.25M | 973K | 1.04M | 1.1M | 12K | 24K | 457K | 485K | 508K | 527K | 441K | 449K | 10K | 36K | 59K | 32K | 21K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 107.12M | 142.54M | 151.76M | 23.05M | 23.95M | 18.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 103K | 103K | 103K | 103K | 103K | 43K | 43K | 12K | 12K | 18K | 18K | 18K | 18K | 12K | 12K | 36K | 24K | 24K | 24K | 24K |
| Total Assets | 504.48M | 488.62M | 509.25M | 357.42M | 377.11M | 396.02M | 414.09M | 33.84M | 36.71M | 51.01M | 54.92M | 60.19M | 65.34M | 69.18M | 50.43M | 51.98M | 11.63M | 7.46M | 8.54M | 9.95M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 33.77% | 23.38% | 22.98% | 956.07% | 927.39% | - | - | - | - | -26.26% | 8.91% | 15.79% | 461.66% | 827.26% | 490.78% | 422.48% | 11.98% | -13.3% | 25.07% | 17.81% |
| Total Current Liabilities | 16.63M | 15.37M | 20.97M | 12.11M | 11.72M | 13.04M | 18.04M | 1.27M | 1.58M | 2.72M | 3.5M | 3.18M | 3.69M | 2.88M | 3.5M | 1.53M | 1.33M | 1.16M | 926K | 1.15M |
| Accounts Payable | 3.66M | 4.16M | 2.21M | 4.66M | 3.54M | 3.46M | 8.5M | 571K | 0 | 1.01M | 1.12M | 1.13M | 2.19M | 1.58M | 1.77M | 761K | 576K | 167K | 418K | 135K |
| Days Payables Outstanding | 8.18K | 10.45K | - | - | - | - | - | - | - | 3.42K | 3.69K | 5.65K | 9.01K | 8.87K | 7.29K | 2.37K | 1.3K | 1.06K | 1.06K | 813.36 |
| Short-Term Debt | 680K | 619K | 419K | 660K | 283K | 213K | 146K | 24K | 48K | 103K | 100K | 97K | 87K | 56K | 41K | 0 | 25K | 50K | 25K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 10.58M | 5.33M | 15.49M | 5.1M | 7.08M | 7.33M | 8.47M | 567K | 1.45M | 1.43M | 1.36M | 1.81M | 1.22M | 991K | 870K | 545K | 575K | 749K | 354K | 857K |
| Current Ratio | 23.76x | 22.37x | 16.94x | 27.42x | 30.03x | 28.89x | 22.89x | 26.61x | 23.19x | 18.59x | 15.56x | 18.75x | 17.54x | 23.86x | 14.28x | 34.01x | 8.71x | 6.39x | 9.16x | 8.61x |
| Quick Ratio | 23.76x | 22.37x | 16.94x | 27.42x | 30.03x | 28.89x | 22.89x | 26.61x | 23.19x | 18.59x | 15.56x | 18.75x | 17.54x | 23.86x | 14.28x | 34.01x | 8.71x | 6.39x | 9.16x | 8.61x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.13M | 1.31M | 1.49M | 1.67M | 664K | 755K | 53.68M | 0 | 0 | 357K | 383K | 410K | 435K | 394K | 409K | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.13M | 1.31M | 1.49M | 1.67M | 664K | 755K | 842K | 0 | 0 | 357K | 383K | 410K | 435K | 394K | 409K | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 52.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 17.76M | 16.69M | 22.46M | 13.78M | 12.39M | 13.8M | 71.72M | 1.27M | 1.58M | 3.08M | 3.88M | 3.59M | 4.13M | 3.27M | 3.91M | 1.53M | 1.33M | 1.16M | 926K | 1.15M |
| Total Debt | 1.81M | 1.93M | 1.91M | 2.33M | 947K | 968K | 988K | 24K | 48K | 460K | 483K | 507K | 522K | 450K | 450K | 0 | 25K | 50K | 25K | 0 |
| Net Debt | -47.71M | -45M | -89.34M | -63.07M | -82.63M | -60.61M | -409.89M | -33.26M | -35.85M | -48.6M | -52.88M | -57.81M | -62.67M | -66.48M | -48.62M | -51.09M | -11.02M | -6.62M | -8.34M | -9.64M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | - | 0.00x | 0.01x | 0.00x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | -55.79x | - | - | - | - | - | - | - | - | -994.50x | -436.00x | -329.00x | - | -1197.00x |
| Total Equity | 486.72M | 471.93M | 486.79M | 343.64M | 364.73M | 382.22M | 342.37M | 32.57M | 35.13M | 47.94M | 51.04M | 56.6M | 61.21M | 65.91M | 46.52M | 50.45M | 10.3M | 6.31M | 7.61M | 8.8M |
| Equity Growth % | 33.45% | 23.47% | 42.18% | 954.99% | 938.36% | - | - | - | - | -27.27% | 9.72% | 12.18% | 493.96% | 945.18% | 511.31% | 473.42% | 12.14% | -13.83% | 26.16% | 17.9% |
| Book Value per Share | 8.82 | 8.67 | 11.05 | 8.14 | 8.75 | 22.77 | 22.80 | 2.25 | 2.42 | 39.92 | 42.51 | 47.13 | 50.97 | 64.01 | 58.47 | 100.17 | 68.93 | 47.47 | 57.29 | 69.41 |
| Total Shareholders' Equity | 486.72M | 471.93M | 486.79M | 343.64M | 364.73M | 382.22M | 342.37M | 32.57M | 35.13M | 47.94M | 51.04M | 56.6M | 61.21M | 65.91M | 46.52M | 50.45M | 10.3M | 6.31M | 7.61M | 8.8M |
| Common Stock | 50K | 49K | 48K | 37K | 37K | 37K | 35K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 10K | 9K | 2K | 2K | 2K | 2K |
| Retained Earnings | -220.98M | -189.16M | -159.57M | -129.3M | -104.72M | -83.72M | -57.94M | -193.43M | -190.75M | -176.75M | -173.48M | -167.8M | -163.09M | -158.25M | -154.15M | -149.03M | -147.04M | -145.74M | -144.42M | -143.19M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -480K | 546K | 185K | -27K | -6K | -41K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |